Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brekke

Showing results (871-880 of 947) with videos related to

Pageof 95
Sort By:
Applied and Environmental Microbiology|July 18, 2024
Impact of mineral and non-mineral sources of iron and sulfur on the metalloproteome of <i>Methanosarcina barkeri</i>James Larson, Monika Tokmina-Lukaszewska, Devon Payne, et al.
BMC Health Services Research|November 16, 2023
Guideline evaluation and implementation mechanisms in school health services (GuideMe): protocol for a hybrid randomized factorial trialÅse Sagatun, Thomas Engell, Malene Brekke, et al.
Atherosclerosis|May 14, 2021
Cholesterol at ages 6, 12 and 24 months: Tracking and associations with diet and maternal cholesterol in the Infant Cholesterol StudyLinn K L Øyri, Martin P Bogsrud, Anne Lene Kristiansen, et al.
Human Brain Mapping|February 4, 2015
Default-mode network functional connectivity is closely related to metabolic activitySusanne Passow, Karsten Specht, Tom Christian Adamsen, et al.
Clinical and Experimental Immunology|November 17, 2018
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4A Landsem, H Fure, J Krey Ludviksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcomeRolf I Skotheim, Anne Kallioniemi, Bodil Bjerkhagen, et al.
Hypertension (Dallas, Tex. : 1979)|March 5, 2014
Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertensionFadl Elmula M Fadl Elmula, Pavel Hoffmann, Anne C Larstorp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2019
Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue FactorCaroline S Gravastrand, Bjørg Steinkjer, Bente Halvorsen, et al.
Molecular Immunology|August 16, 2011
Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human bloodOle-Lars Brekke, Bernt Christian Hellerud, Dorte Christiansen, et al.
Neuro-Oncology|February 3, 2009
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumorsHelge R Brekke, Matthias Kolberg, Rolf I Skotheim, et al.
Pageof 95

Showing results (871-880 of 947) with videos related to

Sort By:
Pageof 95
Applied and Environmental Microbiology|July 18, 2024
Impact of mineral and non-mineral sources of iron and sulfur on the metalloproteome of <i>Methanosarcina barkeri</i>James Larson, Monika Tokmina-Lukaszewska, Devon Payne, et al.
BMC Health Services Research|November 16, 2023
Guideline evaluation and implementation mechanisms in school health services (GuideMe): protocol for a hybrid randomized factorial trialÅse Sagatun, Thomas Engell, Malene Brekke, et al.
Atherosclerosis|May 14, 2021
Cholesterol at ages 6, 12 and 24 months: Tracking and associations with diet and maternal cholesterol in the Infant Cholesterol StudyLinn K L Øyri, Martin P Bogsrud, Anne Lene Kristiansen, et al.
Human Brain Mapping|February 4, 2015
Default-mode network functional connectivity is closely related to metabolic activitySusanne Passow, Karsten Specht, Tom Christian Adamsen, et al.
Clinical and Experimental Immunology|November 17, 2018
Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4A Landsem, H Fure, J Krey Ludviksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcomeRolf I Skotheim, Anne Kallioniemi, Bodil Bjerkhagen, et al.
Hypertension (Dallas, Tex. : 1979)|March 5, 2014
Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertensionFadl Elmula M Fadl Elmula, Pavel Hoffmann, Anne C Larstorp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2019
Cholesterol Crystals Induce Coagulation Activation through Complement-Dependent Expression of Monocytic Tissue FactorCaroline S Gravastrand, Bjørg Steinkjer, Bente Halvorsen, et al.
Molecular Immunology|August 16, 2011
Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human bloodOle-Lars Brekke, Bernt Christian Hellerud, Dorte Christiansen, et al.
Neuro-Oncology|February 3, 2009
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumorsHelge R Brekke, Matthias Kolberg, Rolf I Skotheim, et al.
Pageof 95